Bristol-Myers Squibb (China) Investment Co., Ltd.

百时美施贵宝(中国)投资有限公司

Contact Info

Business Scope

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb made its debut in China in 1982 with the establishment of the Sino-American Shanghai Squibb; the first Sino-American pharmaceutical joint venture in China. Bristol-Myers Squibb is a recognized leader in key disease areas, including hepatitis, oncology and immuno-oncology. For more information about Bristol-Myers Squibb in China, please visit www.bms.com.cn.

百时美施贵宝是一家以“研发并提供创新药物,帮助患者战胜严重疾病”为使命的全球性生物制药公司。 百时美施贵宝于1982年进入中国,于同年成立的中美上海施贵宝制药有限公司是在中国成立的第一家中美合资制药企业。公司在肝炎、肿瘤和免疫肿瘤等疾病领域处于行业领先地位。 如需了解更多信息,请浏览百时美施贵宝中国官方网站 www.bms.com.cn。